COST-EFFECTIVENESS OF ASPIRIN IN SECONDARY PREVENTION OF CORONARY HEART-DISEASE

被引：0
|
作者：
GASPOZ, JM
GOLDMAN, P
WILLIAMS, L
WEINSTEIN, M
GOLDMAN, L
机构：
[1] UNIV HOSP,GENEVA,SWITZERLAND
[2] HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115
[3] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
来源：
CIRCULATION | 1995年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of aspirin for the primary prevention of coronary heart disease
    Rodondi, Nicolas
    Moran, Andrew
    Coxson, Pamela G.
    Lightwood, James
    Williams, Lawrence W.
    Cornuz, Jacques
    Goldman, Lee
    [J]. CIRCULATION, 2006, 114 (18) : 827 - 827
  • [2] COST-EFFECTIVENESS OF ALTERNATIVE INTERVENTIONS FOR THE PREVENTION AND TREATMENT OF CORONARY HEART-DISEASE
    CROWLEY, S
    DUNT, D
    DAY, N
    [J]. AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1995, 19 (04): : 336 - 346
  • [3] COST-EFFECTIVENESS PERSPECTIVES IN CORONARY HEART-DISEASE
    GOLDMAN, L
    [J]. AMERICAN HEART JOURNAL, 1990, 119 (03) : 733 - 740
  • [4] The cost-effectiveness of the SPHERE intervention for the secondary prevention of coronary heart disease
    Gillespie, Paddy
    O'Shea, Eamon
    Murphy, Andrew W.
    Byrne, Mary C.
    Byrne, Molly
    Smith, Susan M.
    Cupples, Margaret E.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (03) : 263 - 271
  • [5] COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITION FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    GOLDMAN, L
    WEINSTEIN, MC
    GOLDMAN, PA
    WILLIAMS, LW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (09): : 1145 - 1151
  • [6] COST-EFFECTIVENESS OF ANTIHYPERLIPEMIC THERAPY IN THE PREVENTION OF CORONARY HEART-DISEASE - THE CASE OF CHOLESTYRAMINE
    OSTER, G
    EPSTEIN, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (17): : 2381 - 2387
  • [7] Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
    Gaspoz, J
    Coxson, PG
    Goldman, PA
    Williams, LW
    Kuntz, KM
    Hunink, MGM
    Goldman, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1800 - 1806
  • [8] Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness
    Ho, WK
    Hankey, GJ
    Eikelboom, JW
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 493 - 503
  • [9] ECONOMICS OF INTERVENTION ON BLOOD CHOLESTEROL FOR CORONARY HEART-DISEASE PREVENTION - EVIDENCE FOR COST-EFFECTIVENESS
    RECKLESS, JPD
    [J]. ATHEROSCLEROSIS, 1989, 79 (01) : 94 - 94
  • [10] A COST-EFFECTIVENESS ANALYSIS OF ALTERNATIVE STRATEGIES FOR THE PREVENTION OF HEART-DISEASE
    HALL, J
    HELLER, R
    DOBSON, A
    LLOYD, D
    SANSONFISHER, R
    LEEDER, S
    [J]. COMMUNITY HEALTH STUDIES, 1986, 10 (03): : 373 - 373
12345